Vaxart, Inc. Restructuring and Related Cost, Cost Incurred to Date
Discontinued › Notes
us-gaap:RestructuringAndRelatedCostCostIncurredToDate1 · last filed 2022-02-24
- 2021-12-31: Restructuring and Related Cost, Cost Incurred to Date $4.07M.
- 2020-12-31: Restructuring and Related Cost, Cost Incurred to Date $4.07M.
- 2020-09-30: Restructuring and Related Cost, Cost Incurred to Date $4.07M.
- 2020-06-30: Restructuring and Related Cost, Cost Incurred to Date $5.02M.
| Period end | Restructuring and Related Cost, Cost Incurred to Date |
|---|---|
| 2021-12-31 | $4.07M 10-K · filed 2022-02-24 |
| 2020-12-31 | $4.07M 10-K · filed 2021-02-25 |
| 2020-09-30 | $4.07M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $5.02M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $4.98M 10-Q · filed 2020-05-12 |